Page last updated: 2024-08-24

fluorodeoxyglucose f18 and guanfacine

fluorodeoxyglucose f18 has been researched along with guanfacine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kovalik, E; Mandelkern, MA; Swartz, BE; Thomas, K; Torgersen, D	1

Trials

1 trial(s) available for fluorodeoxyglucose f18 and guanfacine

Article	Year
The effects of an alpha-2 adrenergic agonist, guanfacine, on rCBF in human cortex in normal controls and subjects with focal epilepsy. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2000, Volume: 23, Issue:3 Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Adult; Blood Pressure; Cerebral Cortex; Cerebrovascular Circulation; Epilepsies, Partial; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Guanfacine; Humans; Male; Memory, Short-Term; Middle Aged; Psychomotor Performance; Radiopharmaceuticals; Tomography, Emission-Computed	2000

Article

Year

The effects of an alpha-2 adrenergic agonist, guanfacine, on rCBF in human cortex in normal controls and subjects with focal epilepsy.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2000, Volume: 23, Issue:3

Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Adult; Blood Pressure; Cerebral Cortex; Cerebrovascular Circulation; Epilepsies, Partial; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Guanfacine; Humans; Male; Memory, Short-Term; Middle Aged; Psychomotor Performance; Radiopharmaceuticals; Tomography, Emission-Computed

2000